Home > News > Regional
Saturday July 19, 2014 MYT 12:00:00 AM
Saturday July 19, 2014 MYT 7:16:03 AM
Beijing: Chinese-made vaccines for Japanese Encephalitis are expected to be exported by early next year to needy South-East Asian countries, protecting children there from the lethal virus.
“So far, we’ve received an application for JE vaccine support from Laos, and we are still open to applications from other ... eligible countries also burdened by the disease,” Seth Berkley, CEO of the Global Alliance for Vaccines and Immunisation, a public/private global health partnership, said during a visit to the country that concluded on Thursday.
If everything goes smoothly, “children in applicant countries will get the shots in the first quarter of 2015”, he said.
The disclosure follows an announcement early this month by Margaret Chan, director-general of the World Health Organisation, that the China Food and Drug Administration’s regulatory system for vaccines had passed the WHO assessment.
Additionally, the Japanese Encephalitis vaccine produced by Chengdu Institute of Biological Products of Sinopharm received WHO pre-qualification in October, which means it’s up to international standards for quality, safety and efficacy.
It’s the first Chinese-made vaccine recognised by the programme but probably won’t be the last, according to Bernhard Schwartlander, the WHO representative in China.
Berkley said that “besides children in China, others in poor countries can benefit from international-standard quality products as well” via the Global Alliance for Vaccines and Immunisation.
More than four billion people live in Japanese Encephalitis-endemic areas worldwide, mostly in South-East Asia and the western Pacific, according to the WHO.
Zhang Li, the senior manager of GAVI, said countries with annual per capita incomes under US$1,570 (RM5,000) are eligible to apply for vaccine support.
Potential applicants include Nepal, Bangladesh, Pakistan, Vietnam and Cambodia, she said.
According to GAVI’s budget, financial support for the Japanese Encephalitis vaccine project will be about US$105mil (RM334mil) between 2015 and 2020, and the expenses for implementation and routine immunisation will be borne by the aided countries themselves.
“Applications are accepted on condition that the vaccine will be included in the national immunisation programmes of the aided countries,” she said.
Ge Yonghong, managing director of the Chengdu Institute of Biological Products, said the company had increased production capacity during the pre-qualification process.
“The output of the JE vaccine could meet demands both at home and overseas,” he said.
It took the company more than seven years to get the WHO pre-qualification, and “it’s just the beginning for Chinese-made vaccines to go abroad and protect children worldwide”, he said.
Berkley agreed, saying the Chinese JE vaccine is the best of its kind worldwide and “China’s vaccine industry is highly likely to benefit children in poor countries with quality vaccines at affordable prices”.
It also helps China establish a name brand globally for its vaccines, he said. — China Daily / Asia News Network
Tags / Keywords:
Dengue vaccine not good enough
WHO: China has made huge progress battling TB
China climate negotiator laments 'severe' pollution
Indonesia ready to mediate in South China Sea, says Widodo
China web firms odds on winner with World Cup gambling
Argentina president, back after sick leave, vows to fight hedge funds
More U.S. troops deployed in Ferguson to guard against fresh riots
You can run but you can’t hide
Myanmar political leaders to hold talks on amending constitution
China, Mexico officials meet, no mention of scrapped rail deal
Coal mine fire kills 24 in China
Gecko-feet gloves to climb glass walls
TripAdvisor’s Travellers’ Choice All-Inclusive Resorts
China's Tencent partners with HBO for TV show streaming
Copyright © 1995-2014 Star Publications (M) Bhd (Co No 10894-D)